New!

HyTest Live Webinar - Diagnostics of COVID-19: Achievements, Challenges and Perspectives

Published: 17.09.2020

undefinedWelcome to our live Webinar!
Sign up below.

TIME: Thu, Oct 29, 2020 6:00 PM - 7:00 PM EET

By attending this webinar, you will learn about:
- transmission and clinical characteristics of SARS-CoV-2
- the existing testing methods for SARS-CoV-2, including nucleic acid testing, genome sequencing, serological testing for SARS-CoV-2 specific antibodies and antigen testing
- the principles, advantages and limitations of these testing methods
- safety precautions for handling different types of clinical specimens for SARS-CoV-2 detection

Please register by entering your name, organization and email address below.

SPEAKER:
Dr. Alexander Semenov, Project Manager, R&D Department, HyTest Ltd.
PANELIST:
Dr. Karina Seferian, Project Manager, R&D Department, HyTest Ltd.

AGENDA:
- Welcome and introductions
- Detecting and measuring the levels of SARS-CoV-2 antibodies as a result of exposure to COVID-19 will provide valuable information on the development of individual immunity. During the webinar, the existing testing methods for SARS-CoV-2, as well as the importance of serological testing of SARS-CoV-2, will be described.
- Questions & Answers session

SPEAKER BIO:
Dr. Alexander Semenov is an acknowledged scientist. Since 2005, Alexander has been involved in various different research projects that have focused on BNP and NT-proBNP. The results of these studies have been presented at high-level international journals and conferences, and were indeed twice honored with National Academy of Clinical Biochemistry distinguished abstract awards. Alexander is a member of the reviewing team for protein biomarkers standardization of The Joint Committee for Traceability in Laboratory Medicine (JCTLM).

PANELIST BIO:
Dr. Karina Seferian is a senior scientist at HyTest. She holds a PhD in biochemistry and works on the development of monoclonal antibodies for diagnostics with a focus on cardiac diseases and inflammation. Karina has been involved in research projects related to the heart failure biomarker BNP. Ongoing research is focused on the inflammatory biomarker serum amyloid A (SAA).

undefined


Sign up to our newsletter

And be informed about new products and scientific findings

Thank you for your subscription!